A&E testing scheme finds thousands of people with HIV and hepatitis
Register for free to read more of the latest local news. It's easy and will only take a moment.
A new NHS pilot scheme in A&E departments has helped diagnose thousands of people with HIV and hepatitis.
As part of the programme, people in A&E who are having blood taken for any reason can offer an additional sample, which is then screened for HIV, hepatitis B and hepatitis C.
A positive test means patients are then given access to specialist support and a treatment plan.
According to NHS England, the pilot has helped almost 2,000 people infected with HIV or hepatitis who were previously undiagnosed.
About 470 who had been diagnosed but were not receiving care were also identified and offered treatment.
The £20 million scheme means the testing programme, which started in April 2022, can run in 33 hospital emergency departments over three years, NHS England said.
It has been incredible to see how opt-out testing has changed the lives of people living with HIV
Professor Sir Stephen Powis, NHS national medical director, said: “Effective testing for blood-borne viruses is vital in helping us identify and treat more people living with HIV and hepatitis, so we are very pleased with the positive impact of our routine opt-out testing programme.
“Increasing the early detection and diagnoses of HIV, hepatitis and other blood borne viruses, enables us to provide people with better access to the latest and most effective life-saving medication, which can prevent long-term health issues and reduces the chance of unknown transmissions to others.”
Anne Aslett, chief executive at Elton John AIDS Foundation, added: “When the Elton John AIDS Foundation first piloted opt-out HIV testing in emergency departments in south London, the results were not only staggering, they also paved the way for opt-out HIV testing to go country wide.
“Since opt-out testing in the highest prevalence areas began last April, the system has diagnosed people from the ages of 18 to 85. It has been incredible to see how opt-out testing has changed the lives of people living with HIV.”
According to NHS data, 42% of HIV diagnoses in the UK are when the patient’s immune system is already significantly damaged.
Research shows people who received a late diagnoses are eight times more likely to die from the illness.
Richard Angell, chief executive at Terrence Higgins Trust, said expanding testing for HIV and hepatitis in A&E was “essential” to the organisation meeting its goal of ending new HIV cases by 2030.
He added: “The results from one year of opt-out testing in areas with very high HIV prevalence are above and beyond what anyone expected and have demonstrated an incredible return on investment.”
